Passage Bio, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Flagged at $3.71 at 01:02 PM on Oct 12, then ran to $4.55 +22% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is PASG up today? It is at $3.51 (+3.24%), and our scanner flagged it 3 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PASG spikes, and full due diligence on PASG — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PASG 3 times in the last 30 days. Create a free account to track $PASG, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PASG from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PASG today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMerger / acquisition agreementPrice $1.3861/share, from an SEC filing. Read it →Latest filingEFFECTRegistration declared effectiveOct 13, 2026 · 22 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
About $100.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +50K 1.6% of company | added 8.0% | 674K | $206K at $4.12 | Jun 25, 26 |
Borthwick Kathleen Officer | Sold (automatic/other) | -2K 0.06% of company | sold 28% | 5K | $38K at $18.44 | Jan 8, 26 |
Borthwick Kathleen Officer | Other | 5K 0.2% of company | added 100% | 7K | n/a | Jan 8, 26 |
Chou William Officer | Sold (automatic/other) | -4K 0.1% of company | sold 38% | 7K | $75K at $18.44 | Jan 8, 26 |
Chou William Officer | Other | 10K 0.3% of company | added 100% | 11K | n/a | Jan 8, 26 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +12K 0.4% of company | added 1.9% | 624K | $83K at $6.99 | Sep 15, 25 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +20K 0.6% of company | added 3.3% | 612K | $138K at $6.99 | Sep 12, 25 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +325 0.01% of company | added <0.1% | 592K | $2K at $6.96 | Sep 11, 25 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +66K 2.1% of company | added 13% | 592K | $379K at $5.71 | Jul 24, 25 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +49K 1.5% of company | added 10% | 525K | $283K at $5.74 | Jul 23, 25 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +13K 0.4% of company | added 2.8% | 476K | $71K at $5.44 | Jul 22, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on PASG from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PASG today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
PASG last traded at $3.51, up 3.24% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Passage Bio, Inc. Common Stock (PASG) is next expected to report earnings on Monday, November 9, 2026, about 5 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PASG Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PASG 3 times in the last 30 days.
PASG (Passage Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $11M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PASG for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PASG discussion
Sign in to ask a question or join the discussion.